ProTAME

ProTAME is an APC/C inhibitor that synergizes with topoisomerase II inhibitors like doxorubicin to enhance cell death, particularly in Multiple Myeloma models, by first elevating TOPIIα levels. Its application in cancer research includes in vitro studies on cell cycle arrest and apoptosis, though its instability necessitates the use of stabilized salt forms.